1. Dexmedetomidine reduces IL-4 and IgE expression through downregulation of theTLR4/NF-κB signaling pathway to alleviate airway hyperresponsiveness in OVA mice
   Juan Zhi et al, 2022, Pulmonary Pharmacology & Therapeutics CrossRef
2. Dexmedetomidine attenuates airway inflammation and oxidative stress in asthma via the Nrf2 signaling pathway
   Shilin Xiao et al, 2022, Molecular Medicine Reports CrossRef
3. Ketamine Attenuates Airway Inflammation via Inducing Inflammatory Cells Apoptosis and Activating Nrf2 Pathway in a Mixed-Granulocytic Murine Asthma Model
   Shilin Xiao et al, 2022, Drug Design, Development and Therapy CrossRef
4. Advances in respiratory physiology in mouse models of experimental asthma
   Olivia R. Carroll et al, 2023, Frontiers in Physiology CrossRef
5. Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway
   Ying Zhou et al, 2023, Mediators of Inflammation CrossRef
6. Effects of dexmedetomidine on dynamic lung compliance in general anesthesia with desflurane: A randomized controlled study
   Xiaoli Wang et al, 2023, Heliyon CrossRef